Quarterly report pursuant to Section 13 or 15(d) 09-30-2017

Document and Entity Information

v3.8.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2017
Dec. 29, 2017
Document And Entity Information    
Entity Registrant Name AMEDICA Corp  
Entity Central Index Key 0001269026  
Document Type 10-Q/A  
Document Period End Date Sep. 30, 2017  
Amendment Flag true  
Amendment Description

This Amendment No. 2 on Form 10-Q/A for the quarter ended September 30, 2017, amends the Form 10-Q/A that was originally filed with the U.S. Securities and Exchange Commission on November 14, 2017 (the “Original Filing”). The sole purpose of this Amendment No. 2 is to correct the condensed consolidated balance sheet as of September 30, 2017 and the statements of operations and cash flows for the periods ended September 30, 2017, to include a derivative liability from the issuance of 1,054,167 common stock warrants during July 2016 and the issuance of 333,750 common stock warrants during January 2017 that were previously recorded as equity. Based on the Company’s reassessment of relevant accounting guidance, the effect of this adjustment resulted in a decrease to a non-cash other expense, an increase in a derivative liability and a decrease to additional paid-in capital. In addition, on November 10, 2017, the Company effected a 1 for 12 reverse stock split of the Company’s common stock. The par value and the authorized shares of the common and convertible preferred stock were not adjusted as a result of the reverse stock split. All common stock share and per-share amounts for all periods presented in these condensed consolidated financial statements have been adjusted retroactively to reflect the reverse stock split. The following financial statements and disclosures were impacted from the correction and reverse stock split:

 

  Updated the Condensed Consolidated Balance Sheet as of September 30, 2017, and the related statements of operations and cash flows for the periods then ended.
  Updated Note 1 – Reverse Stock Split to explain the 1 for 12 reverse common stock split.
  Updated Note 5 – Fair Value Measurements for the derivative liability from the issuance of warrants and the related assumptions used in valuing the derivative.
  Updated Note 7 – Debt for adjustments to common stock and common stock warrant numbers adjusted for the reverse stock split.
  Updated Note 8 – Equity for adjustments to common stock and common stack warrant numbers adjusted for the reverse stock split.
  Updated Note 9 – Stock Based Compensation for adjustments to common stock and common stock option numbers adjusted for the reverse stock split.
  Added Note 11 – Restatement of Condensed Consolidated Balance Sheet and related Statement of Operations and Cash Flows.
  Additionally, we have also updated the signature page, the certifications of our Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2, and 32, and our financial statements formatted in Extensible Business Reporting Language (XBRL) in Exhibits 101.

 

In addition to the above financial statement and related disclosure corrections outlined, corresponding adjustments have been made related to the Reverse Stock Split, and corresponding adjustments to Item 2: Management’s discussion and analysis of financial condition and results of operations have also been made. Except as described above, no other changes have been made to the Original Filing or any other exhibits. This Amendment speaks as of the filing date of the Original Filing and does not reflect events occurring after the filing date, or modify or update those disclosures that may be affected by subsequent events, except for the reverse common stock split mentioned above. As such, this form 10-Q/A should be read in conjunction with the original filing.

 
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   3,022,073
Trading Symbol AMDA  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2017